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510Parallel Pathways
of Virus Recognition
Viruses trigger signaling pathways of innate immu-
nity. In this issue, Sun et al. (2006) show that the mito-
chondrial antiviral signaling protein is critical for intra-
cellular detection signaling, but is dispensable for the
activation of innate immunity via Toll-like receptors.
Our understanding of the molecular machinery required
for the recognition of virus infection has been shaped
by the discovery of two complementary pathways medi-
ated by pattern-recognition receptors (Kawai and Akira,
2006). Extracellular viral components bind to transmem-
brane-anchored, endosomal members of the Toll-like re-
ceptor (TLR) family and transduce a signal via cytoplas-
mic adaptor proteins. In the other pathway, cytoplasmic
receptors such as the retinoic-acid-inducible gene I
(RIG-I) mediate the induction of response genes from in-
tracellular pathogen-produced substrates (Kawai and
Akira, 2006). After the engagement of these specialized
receptors, adaptor proteins assemble to form multisub-
unit complexes that activate kinases such as the ca-
nonical IKK complex, the IKK-related kinases (TBK1
and IKK3), and IRAK1-IKKa. These kinases then phos-
phorylate downstream targets (inhibitors or activators),
leading to the activation of NF-kB and IRF family mem-
bers of transcription factors (Hoshino et al., 2006; Kawai
and Akira, 2006). The end result of these signaling path-
ways is the assembly of an enhanceosome, the tran-
scription enhancer complex that drives expression of
the interferon beta (IFN-b) gene (Maniatis et al., 1998)
(Figure 1).
IFN-b is a pleiotropic cytokine that orchestrates the
coordination of innate and adaptive immunity in re-
sponse to virus infection. The discovery of the mito-
chondrial antiviral signaling (MAVS) protein provided a
missing component linking TLR- and RIG-I-dependent
signaling events to the downstream kinases responsible
for enhanceosome assembly. MAVS was simultaneously
discovered by four independent groups and is alsoreferred to as the IFN-b promoter stimulator 1 (IPS-1),
CARD adaptor inducing IFN-b (Cardif), and virus-
induced signaling adaptor (VISA) (Kawai and Akira,
2006; Kawai et al., 2005; Seth et al., 2005; Xu et al.,
2005). These studies revealed interactions between
MAVS and a number of components involved in both
the intracellular and extracellular detection machinery,
suggesting that signaling from all pattern-recognition re-
ceptors converges on this mitochondrial adaptor.
Now, a decisive study in this issue of Immunity (Sun
et al., 2006) confirms the critical role of MAVS in mediat-
ing RIG-I-dependent signaling, but reveals that MAVS
does not serve as a downstream target of RIG-I-inde-
pendent pathogen recognition. Through the generation
of Mavs2/2 mice, Sun et al. investigated the ex vivo role
of MAVS in response to infection by both virus (Sendai
virus and double-stranded RNA [dsRNA]) and bacteria
(lipopolysaccharide [LPS], cytoplasmic DNA, and Liste-
ria monocytogenes). In the case of virus infection, they
find that MAVS is required for IFN-b production in all cell
types examined, except plasmocytoid dendritic cells
(pDCs). In contrast, MAVS is not required for IFN-b pro-
duction in response to extracellular dsRNA through
TLR3, to LPS through TLR4, to treatment with cytoplas-
mic DNA, or in response to infection by Listeria monocy-
togenes. This was true for all cell types examined. These
findings, contrary to initial reports (Xu et al., 2005), con-
clusively demonstrate that MAVS is a unique adaptor of
the RIG-I pathway.
Studies were also carried out to investigate the role of
MAVS in the antiviral response in vivo. Wild-type and
Mavs2/2mice were infected with Vesicular Stomatitis Vi-
rus (VSV), and the amounts of IFN-b were determined.
Despite the lack of IFN-b production ex vivo in virus-
infected Mavs2/2 embryonic fibroblasts (MEFs), bone-
marrow-derived macrophages (BMDM), peritoneal mac-
rophages, or conventional dendritic cells (cDC), normal
amounts of IFN-b were observed in Mavs2/2 mice
infected with VSV. This observation is perhaps not
surprising, because pDCs, which respond normally to
virus infection in the absence of MAVS ex vivo, are the
primary source of IFN in response to VSV in vivo (Barchet
et al., 2002). Despite the normal amounts of IFN-b in
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511Figure 1. Virus-Recognition Pathways
Virus replication results in the production of pathogen-associated molecular patterns (PAMPs). Viral PAMPs trigger multiple signaling cascades
through Toll-like-receptor-dependent (TLR3, TLR7, and TLR9) and -independent (RIG-I and MDA5) pathways leading to kinase activation
through TRAF family members. TRIF and MyD88 are the adaptors linking TLRs to the TRAF proteins, whereas MAVS links RIG-1 and MDA5
to TRAF3. TRAF-dependent induction of the kinases JNK, IKKa, IKKb, IKKg, TBK1, and IRAK1 induce the binding of the transcription factors
ATF2-cJun complex, NF-kB (p50-p65 complex), IRF3, and IRF7 to sequence specific positive regulatory domains (PRD) located upstream of
the interferon-b start site. Coordinated assembly of these factors forms the interferon-b enhanceosome, which is responsible for the transcrip-
tional induction of this antiviral cytokine.VSV-infected Mavs2/2 mice, the viral load was 5-fold
greater than in wild-type littermate controls. This re-
sulted in a dramatic increase in mortality. Although these
differences in ex vivo and in vivo results appear contra-
dictory, they highlight differences between the overall
physiological response to virus infection and the intra-
cellular response that occurs at the site of infection. Al-
though pDCs produce high amounts of circulating IFN
systemically to aid in the immune response, the reduced
amount of local IFN production at the site of infection ap-
pears critical for minimizing viral load.
The initial response to virus infection is the production
of IFN-b and the induction of apoptosis. The secreted
IFN-b induces the JAK-STAT signaling pathway in
neighboring cells, leading to the activation of a large
battery of IFN-stimulated genes (ISGs). The timely in-
duction of these ISGs transforms the surrounding cellu-
lar environment into one that suppresses the spread of
virus. This environment is established through the inhi-
bition of the cellular machinery normally pirated by the
virus for its replication, including critical components
of transcription, translation, and intracellular transport
machinery. Slowing the rate of viral replication providestime for the recruitment of antigen-presenting cells
(APCs) and the subsequent establishment of an adap-
tive immune response. Considered in this context, the
Sun et al. study suggests that the predominant mecha-
nism of inhibiting virus replication at the site of infection
requires RIG-I and MAVS.
The conclusion that the RIG-I-MAVS pathway is not
required for TLR signaling raises an interesting question
regarding the physiological role of TLR signaling in the
antiviral response. The TLR signaling pathway is clearly
not sufficient to compensate for the loss of MAVS as in-
dicated by the dramatic increase in virus susceptibility
in ex vivo and in vivo experiments. The TLR-based sig-
naling pathway may therefore be involved in some other
aspect of immune function. This possibility is supported
by the observation that virus-infected Tlr32/2 mice pro-
duce normal amounts of IFN, and they do not display an
increased susceptibility to virus infection, but are im-
paired in aspects of T cell cross-priming (Schulz et al.,
2005). However, given that the ex vivo viral studies mea-
suring viral fitness were only performed in fibroblasts,
the physiological role of TLR7, TLR8, and TLR9 in this
context remains unknown because their expression is
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512limited to APCs. Activation of these TLRs results in the
induction of IFN through a unique mechanism involving
the enzymes IRAK1 and IKKa and the transcription fac-
tor IRF7 (Hoshino et al., 2006). It will therefore be inter-
esting to see whether this pathway provides protection
from VSV in the absence of MAVS.
It is also noteworthy that loss of MAVS expression did
not affect the response to either cytoplasmic DNA or di-
rect infection with Listeria monocytogenes. These data
suggest that signaling through the intracellular receptor
for cytoplasmic DNA requires a unique adaptor that is
independent of MAVS. The existence of distinct cyto-
plasmic receptors such as those involved in the detec-
tion of cytoplasmic DNA, or the intracellular bacterial
sensors NOD1 and NOD2, suggests the possibility that
the transcriptional response is tailored to be pathogen
specific.
Another intriguing unanswered question is the signif-
icance of the mitochondrial localization of MAVS. Does
the mitochondrial localization reveal an evolutionary link
between innate immunity and the origins of eukaryotes,
or does the mitochondrial membrane merely serve as a
common location for virus replication? The finding that
MAVS is inactivated by hepatitis C virus through a mech-
anism involving the cleavage of its mitochondrial anchor
reveals the importance of this localization (Li et al., 2005;
Meylan et al., 2005). However, the question of whether
mitochondria serve a function in the pathogen detection
process remains unknown.Benjamin R. tenOever1 and Tom Maniatis1
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